Crossmark

FR - Brentuximab como tratamiento de los linfomas cutáneos primarios CD30

Crossref DOI link: https://doi.org/10.1016/j.ad.2018.03.025

Published Print: 2019-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Morgado-Carrasco, D.

Combalia, A.

Estrach Panella, T.
License Information

Text and Data Mining valid from 2019-11-01
More Information

This article is maintained by: Elsevier

Article Title: FR - Brentuximab como tratamiento de los linfomas cutáneos primarios CD30

Journal Title: Actas Dermo-Sifiliográficas

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.ad.2018.03.025

Content Type: article

Copyright: © 2018 AEDV. Published by Elsevier España, S.L.U. All rights reserved.